Willis Towers Watson (WTW)
(Delayed Data from NSDQ)
$299.30 USD
-2.89 (-0.96%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $299.32 +0.02 (0.01%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$299.30 USD
-2.89 (-0.96%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $299.32 +0.02 (0.01%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Zacks News
eHealth (EHTH) Soars 13.7%: Is Further Upside Left in the Stock?
by Zacks Equity Research
eHealth (EHTH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Willis Towers (WTW) Banks on Segmental Growth Amid Cost Woes
by Zacks Equity Research
Willis Towers (WTW) holds the potential to reap benefits driven by higher demand for products and advisory work, growth across global lines of business, solid balance sheet and steady cash flow.
Company News for Jul 28, 2023 (Revised)
by Zacks Equity Research
Companies In The News Are: ROKU, IP, WTW, INTC.
Willis Towers (WTW) Q2 Earnings Miss, Revenues Beat Estimates
by Zacks Equity Research
Willis Towers (WTW) Q2 results reflect the solid performance of the Health, Wealth & Career and Risk & Broking segments, which was offset by higher expenses.
Company News for Jul 28, 2023
by Zacks Equity Research
Companies In The News Are: ROKU,IP,WTW,INTC
Willis Towers Watson (WTW) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Willis Towers Watson (WTW) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Willis Towers Watson (WTW) Q2 Earnings Lag Estimates
by Zacks Equity Research
Willis Towers Watson (WTW) delivered earnings and revenue surprises of -13.87% and 1.56%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stocks' Q2 Earnings Due on Jul 27: AJG, CINF & More
by Sushmita Sarker
Strong retention, new business, reinsurance agreements, interest rate hikes and technological advancement are likely to drive second-quarter results of insurers like AJG, CINF, WTW, AMSF and FAF.
What's in the Cards for Willis Towers (WTW) in Q2 Earnings?
by Zacks Equity Research
Willis Towers' (WTW) second-quarter results are likely to have reflected gains from reward-based advisory services, higher levels of project work, and the expansion of local portfolios and lower expenses.
Brown & Brown (BRO) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Brown & Brown (BRO) delivered earnings and revenue surprises of 15.25% and 6.65%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Willis Towers Watson (WTW) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Willis Towers Watson (WTW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Hold Strategy is Apt for Willis Towers (WTW) Stock
by Zacks Equity Research
Willis Towers (WTW) is poised to benefit from growth across global lines of business, strategic inorganic expansion, higher demand for products and advisory work, and a solid balance sheet.
Is SPDR Russell 1000 Low Volatility Focus ETF (ONEV) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for ONEV
Should You Retain Willis Towers (WTW) Stock in Your Portfolio?
by Zacks Equity Research
Willis Towers (WTW) is poised to benefit from growing healthcare premiums, increased consulting work and software sales, strategic buyouts and effective capital deployment.
Should SPDR Russell 1000 Low Volatility Focus ETF (ONEV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for ONEV
Arthur J. Gallagher (AJG) Q1 Earnings Top on Margin Expansion
by Zacks Equity Research
Arthur J. Gallagher's (AJG) Q1 results reflect strong Brokerage and Risk Management segments, pricing increases and consistent primary insurance market conditions.
Willis Towers (WTW) Q1 Earnings, Revenues Top, Increase Y/Y
by Zacks Equity Research
Willis Towers (WTW) Q1 results reflect solid performance of WTW's Health, Wealth & Career segment and lower expenses were offset by the soft performance of the Risk & Broking segment.
Compared to Estimates, Willis Towers Watson (WTW) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Willis Towers Watson (WTW) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Willis Towers Watson (WTW) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Willis Towers Watson (WTW) delivered earnings and revenue surprises of 1.07% and 2.08%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stocks' Q1 Earnings Due on Apr 27: AJG, CINF & More
by Tanuka De
Better pricing, solid retention and renewals, exposure growth and accelerated digitalization are likely to drive first-quarter results of insurers like AJG, CINF, HIG, WTW and KNSL.
What's in the Cards for Willis Towers (WTW) in Q1 Earnings?
by Zacks Equity Research
Willis Towers' (WTW) first-quarter results are likely to reflect gains from increased advisory work, higher levels of project work, reward-based advisory services and expansion of local portfolios and lower expenses.
Willis Towers Watson (WTW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Willis Towers Watson (WTW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Hold Strategy is Apt for Willis Towers (WTW)
by Zacks Equity Research
Willis Towers (WTW) is poised to benefit from growing healthcare premiums, improved client retention, higher software sales and solid balance sheet.
Is SPDR Russell 1000 Low Volatility Focus ETF (ONEV) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for ONEV
Should SPDR Russell 1000 Low Volatility Focus ETF (ONEV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for ONEV